Haleon (HLN) Stock Price, News & Analysis

Company Overview

Haleon plc (NYSE: HLN) is a global consumer health company that develops, manufactures and markets over-the-counter medicines, oral health products, vitamins and supplements. Its portfolio is organized around categories including pain relief, respiratory health, digestive health, therapeutic oral care, everyday oral care, vitamins and minerals, and skin health.

Haleon’s well-known brands include Sensodyne, Polident, parodontax, Centrum, Advil, Voltaren, Panadol, Otrivin and Theraflu. The company’s products are sold through pharmacies, supermarkets, retailers and e-commerce channels, serving consumers in markets around the world.

Haleon was established as an independent consumer health business following its demerger from GSK in July 2022. The company is headquartered in Weybridge, England, and operates internationally with a focus on providing self-care products intended to help consumers manage common health conditions and maintain everyday wellbeing.

Key Stats

• Today's Range: $8.61 to $8.79
• 50-Day Range: $8.56 to $10.38
• 52-Week Range: $8.38 to $11.28
• Volume: 32.53 million shs
• Average Volume: 18.59 million shs
• Market Capitalization: $38.14 billion
• P/E Ratio: 22.21
• Dividend Yield: 1.39%
• Price Target: $4.90
• Consensus Rating: Moderate Buy

Haleon Stock Analysis - MarketRank™

Haleon scored higher than 80% of companies evaluated by MarketBeat, and ranked 45th out of 169 stocks in the consumer staples sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 2.3 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

Haleon has received a consensus rating of Moderate Buy. The company's average rating score is 2.60, and is based on 2 strong buy ratings, 3 buy ratings, 4 hold ratings, and 1 sell rating.

Downside Risk

Haleon has a consensus price target of $4.90, representing about 43.4% downside from its current price of $8.66.

Amount of Analyst Coverage

Haleon has been the subject of 7 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 2.5 / 5
• Proj. Earnings Growth: 7.02%

Earnings Growth

Earnings for Haleon are expected to grow by 7.02% in the coming year, from $0.57 to $0.61 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Haleon is 22.21, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 27.04.

Price to Earnings Ratio vs. Sector

The P/E ratio of Haleon is 22.21, which means that it is trading at a less expensive P/E ratio than the Consumer Staples sector average P/E ratio of about 26.04.

Price to Earnings Growth Ratio

Haleon has a PEG Ratio of 1.93. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

Haleon has a P/B Ratio of 1.77. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.42% of the float of Haleon has been sold short.

Short Interest Ratio / Days to Cover

Haleon has a short interest ratio ("days to cover") of 1.08, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Haleon has recently decreased by 25.36%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 2.5 / 5
• Dividend Strength: Moderate

Dividend Yield

Haleon pays a meaningful dividend of 1.23%, higher than the bottom 25% of all stocks that pay dividends.

Dividend Growth

Haleon does not have a long track record of dividend growth.

Dividend Coverage

The dividend payout ratio of Haleon is 30.77%. This payout ratio is at a healthy, sustainable level, below 75%.

Dividend Sustainability

Based on earnings estimates, Haleon will have a dividend payout ratio of 19.67% next year. This indicates that Haleon will be able to sustain or increase its dividend.

News and Social Media

• Score: 3.4 / 5
• News Sentiment: 0.49

News Sentiment

Haleon has a news sentiment score of 0.49. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Consumer Staples companies.

News Coverage This Week

MarketBeat has tracked 12 news articles for Haleon this week, compared to 1 article on an average week.

Search Interest

6 people have searched for HLN on MarketBeat in the last 30 days. This is an increase of 200% compared to the previous 30 days.

MarketBeat Follows

4 people have added Haleon to their MarketBeat watchlist in the last 30 days.

Company Ownership

• Score: 0.1 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Haleon insiders have not sold or bought any company stock.

Percentage Held by Institutions

6.67% of the stock of Haleon is held by institutions.

Company Calendar

• Last Earnings: 2/27/2025
• Record date for 9/17 Dividend: 8/14/2026
• Ex-Dividend for 9/17 Dividend: 8/14/2026
• Dividend Payable: 9/17/2026
• Today: 10/31/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Consumer Staples
• Industry: Personal Care Products
• Sub-Industry: Personal Care Products
• Current Symbol: NYSE:HLN
• CIK: 1900304
• Web: www.haleon.com
• Phone: 44-19-3282-2000
• Fax: N/A
• Employees: 24,535
• Year Founded: N/A

Price Target and Rating

• Average Price Target for Haleon: $4.90
• High Price Target: $4.90
• Low Price Target: $4.90
• Potential Upside/Downside: -43.4%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.60
• Research Coverage: 10 Analysts

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: 22.21
• Forward P/E Ratio: 15.19
• P/E Growth: 1.93
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: 0.38
• Current Ratio: 0.69
• Quick Ratio: 0.52

Sales & Book Value

• Annual Sales: $11.15 billion
• Price / Sales: 3.42
• Cash Flow: $0.61 per share
• Price / Cash Flow: 14.09
• Book Value: $4.88 per share
• Price / Book: 1.77

Miscellaneous

• Outstanding Shares: 4,404,171,000
• Free Float: N/A
• Market Cap: $38.14 billion
• Optionable: Optionable
• Beta: 0.14